Study Uses Non-invasive Technique To Help Veterans With Depression, Concussion

Promising studies using repetitive T to help veterans and active-duty service members living with depression, post-traumatic stress disorder (PTSD), and other lasting consequences of concussion.

Permalink
Posted: Nov 19 2020

Pilot Study: New Approach to Help Adults with Autism and Depression

Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.

Permalink
Posted: Nov 05 2020

Targeting Brain Circuits in TMS May Relieve Specific Symptoms of Depression

Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.

Permalink
Posted: Oct 22 2020

Intensive Brain Stimulation Lifts Depression In 90% of Patients

Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.

Permalink
Posted: Oct 08 2020

Large-Scale Analysis of Interindividual Variability in Theta-Burst Stimulation Data: Results From the ‘Big TMS Data Collaboration’

Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.

Permalink
Posted: Sep 15 2020

The Future Is Now? Rapid Advances by Brain Stimulation Innovation

Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.

Permalink
Posted: Sep 01 2020

Transcranial Magnetic Stimulation

Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.

Permalink
Posted: Aug 25 2020

Accelerated Intermittent Theta Burst Stimulation Treatment for Depression During COVID-19 Pandemic

Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.

Permalink
Posted: Aug 11 2020

FDA Grants Breakthrough Designation to Transcranial Magnetic Stimulation Device for Bipolar Depression

The system uses transcranial magnetic stimulation (rTMS), a noninvasive form of neuromodulation, to stimulate areas of the brain that are underactive.

Permalink
Posted: Jun 18 2020

A Potentially Powerful Treatment for Refractory Depression

Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.

Permalink
Posted: Jun 04 2020